Oscar Health, Inc.
OSCR
$13.23
$0.231.77%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.80B | 2.98B | 2.86B | 3.04B | 2.39B |
| Total Other Revenue | 8.97M | 8.80M | 6.50M | 4.33M | 4.81M |
| Total Revenue | 2.81B | 2.99B | 2.86B | 3.05B | 2.39B |
| Cost of Revenue | 2.62B | 2.59B | 2.55B | 2.26B | 2.07B |
| Gross Profit | 185.16M | 399.65M | 310.97M | 786.61M | 327.32M |
| SG&A Expenses | 511.03M | 521.59M | 534.49M | 482.76M | 465.82M |
| Depreciation & Amortization | 7.88M | 7.31M | 6.97M | 6.73M | 9.23M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.14B | 3.12B | 3.09B | 2.75B | 2.54B |
| Operating Income | -333.75M | -129.25M | -230.48M | 297.12M | -147.73M |
| Income Before Tax | -352.68M | -139.29M | -233.54M | 288.21M | -153.69M |
| Income Tax Expenses | -247.00K | -1.81M | -5.05M | 12.71M | -404.00K |
| Earnings from Continuing Operations | -352.43M | -137.48M | -228.49M | 275.51M | -153.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -177.00K | 34.00K | 130.00K | -235.00K | -262.00K |
| Net Income | -352.61M | -137.45M | -228.36M | 275.27M | -153.55M |
| EBIT | -333.75M | -129.25M | -230.48M | 297.12M | -147.73M |
| EBITDA | -325.87M | -121.94M | -223.51M | 303.85M | -138.50M |
| EPS Basic | -1.24 | -0.53 | -0.89 | 1.10 | -0.62 |
| Normalized Basic EPS | -0.78 | -0.34 | -0.57 | 0.72 | -0.39 |
| EPS Diluted | -1.25 | -0.53 | -0.89 | 0.92 | -0.68 |
| Normalized Diluted EPS | -0.78 | -0.34 | -0.57 | 0.59 | -0.39 |
| Average Basic Shares Outstanding | 283.25M | 259.27M | 255.53M | 251.28M | 248.21M |
| Average Diluted Shares Outstanding | 283.25M | 259.27M | 255.53M | 305.94M | 248.21M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |